Form 4: Verastem CFO Sells Shares for Tax Obligations
Insider Transaction Report
Verastem's Chief Financial Officer, Daniel Calkins, sold a total of 82 shares of common stock to cover tax withholding requirements related to restricted stock unit vesting.
Summary
- Daniel Calkins, Chief Financial Officer of Verastem, Inc. (VSTM), reported two sales of common stock.
- On September 22, 2025, 57 shares were sold at a price of $9.08 per share.
- On September 24, 2025, an additional 25 shares were sold at a price of $9.23 per share.
- These sales were executed to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.
- The transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- Following these reported transactions, Daniel Calkins beneficially owns 109,838 shares of Verastem common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary sale of shares by an insider to cover tax obligations related to RSU vesting, which is a neutral event with no significant positive or negative implications for the company's operations or financial health.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Minimal direct impact on shareholders as the transaction is a routine tax-related sale by an insider, not indicative of a change in confidence or company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 09/22/2025 | Sale of 57 shares of Verastem common stock by Daniel Calkins. |
| 09/24/2025 | Sale of 25 shares of Verastem common stock by Daniel Calkins; Date of signature for the Form 4 filing. |
Recommendation
holdThe filing details a routine, non-discretionary sale of shares by the CFO to cover tax obligations from RSU vesting. This is a common practice and does not reflect a change in the company's fundamentals or the insider's confidence. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.
Keywords
Verastem, VSTM, Daniel Calkins, CFO, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.